Harrer DC - Search Results

1

Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis.

Harrer DC, Jakob M, Vogelhuber M, Lüke F, Utpatel K, Corbacioglu S, Herr W, Reichle A, Heudobler D. Harrer DC, et al. Leuk Lymphoma. 2022 Dec;63(12):2858-2868. doi: 10.1080/10428194.2022.2095627. Epub 2022 Jul 12. Leuk Lymphoma. 2022. PMID: 35819881

2

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report.

Harrer DC, Menhart K, Mayer S, Herr W, Reichle A, Vogelhuber M. Harrer DC, et al. Front Oncol. 2020 Oct 2;10:585830. doi: 10.3389/fonc.2020.585830. eCollection 2020. Front Oncol. 2020. PMID: 33134180 Free PMC article.

3

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.

Lüke F, Harrer DC, Hahn J, Grube M, Pukrop T, Herr W, Reichle A, Heudobler D. Lüke F, et al. Among authors: harrer dc. Front Pharmacol. 2021 Jun 2;12:599552. doi: 10.3389/fphar.2021.599552. eCollection 2021. Front Pharmacol. 2021. PMID: 34149402 Free PMC article.

4

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease.

Lüke F, Harrer DC, Menhart K, Wolff D, Holler E, Hellwig D, Herr W, Grube M, Vogelhuber M, Reichle A, Heudobler D. Lüke F, et al. Among authors: harrer dc. Front Pharmacol. 2021 Jun 18;12:599561. doi: 10.3389/fphar.2021.599561. eCollection 2021. Front Pharmacol. 2021. PMID: 34220492 Free PMC article.

5

Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas.

Harrer DC, Buschauer S, Sterz U, Menhart K, Wendl C, Heudobler D, Grube M, Pukrop T, Herr W, Vogelhuber M. Harrer DC, et al. Front Oncol. 2021 Dec 14;11:755439. doi: 10.3389/fonc.2021.755439. eCollection 2021. Front Oncol. 2021. PMID: 34970483 Free PMC article.

6

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature.

Harrer DC, Lüke F, Einspieler I, Menhart K, Hellwig D, Utpatel K, Herr W, Reichle A, Heudobler D. Harrer DC, et al. Front Oncol. 2022 May 25;12:886436. doi: 10.3389/fonc.2022.886436. eCollection 2022. Front Oncol. 2022. PMID: 35692786 Free PMC article.

7

Drug Repurposing by Tumor Tissue Editing.

Lüke F, Harrer DC, Pantziarka P, Pukrop T, Ghibelli L, Gerner C, Reichle A, Heudobler D. Lüke F, et al. Among authors: harrer dc. Front Oncol. 2022 Jun 24;12:900985. doi: 10.3389/fonc.2022.900985. eCollection 2022. Front Oncol. 2022. PMID: 35814409 Free PMC article. Review.

8

Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.

Harrer DC, Heidenreich M, Fante MA, Müller V, Haehnel V, Offner R, Burkhardt R, Herr W, Edinger M, Wolff D, Thomas S, Brosig A. Harrer DC, et al. Transfusion. 2022 Aug;62(8):1602-1611. doi: 10.1111/trf.17030. Epub 2022 Jul 19. Transfusion. 2022. PMID: 35851959

9

Unusually swift response of relapsed Burkitt leukemia to R-DHAP.

Harrer DC, Denk A, Keil F, Menhart K, Mayer S, Wolff D, Edinger M, Herr W, Grube M. Harrer DC, et al. EJHaem. 2022 Jun 13;3(3):1003-1008. doi: 10.1002/jha2.501. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051076 Free PMC article.

10

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells.

Harrer DC, Schenkel C, Berking C, Herr W, Abken H, Dörrie J, Schaft N. Harrer DC, et al. Cancers (Basel). 2022 Oct 14;14(20):5033. doi: 10.3390/cancers14205033. Cancers (Basel). 2022. PMID: 36291817 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters